+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Wearable Injector Market Research Report by Type, Application, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 236 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989995
UP TO OFF until Dec 31st 2022
The Global Wearable Injector Market size was estimated at USD 6,358.74 million in 2021, USD 7,057.48 million in 2022, and is projected to grow at a CAGR of 11.16% to reach USD 12,000.44 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Wearable Injector to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Body Worn Patch Injector and Off Body Worn Patch Injector.
  • Based on Application, the market was studied across Autoimmune Disease, Cardiovascular Disease, Diabetes, Infectious Disease, and Oncology.
  • Based on End Use, the market was studied across Clinic, Home Care Setting, Hospital, Online Pharmacy, Retail Pharmacy, and Specialty Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wearable Injector market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wearable Injector Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wearable Injector Market, including Amgen Inc., BASF SE, Becton, Dickinson and Company, DCA Design International Ltd, E3D Elcam Drug Delivery Devices, Gerresheimer AG, Insulet Corporation, Johnson & Johnson, Medtronic PLC, Neuma LLC, SCHOTT AG, SONCEBOZ SA, Stevanato Group S.p.A., Valeritas, Inc., West Pharmaceutical Services, Inc., and Ypsomed AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Wearable Injector Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wearable Injector Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Injector Market?
4. What is the competitive strategic window for opportunities in the Global Wearable Injector Market?
5. What are the technology trends and regulatory frameworks in the Global Wearable Injector Market?
6. What is the market share of the leading vendors in the Global Wearable Injector Market?
7. What modes and strategic moves are considered suitable for entering the Global Wearable Injector Market?
Frequently Asked Questions about the Global Wearable Injector Market

What is the estimated value of the Global Wearable Injector Market?

The Global Wearable Injector Market was estimated to be valued at $6358.74 Million in 2021.

What is the growth rate of the Global Wearable Injector Market?

The growth rate of the Global Wearable Injector Market is 11.1%, with an estimated value of $12000.44 Million by 2027.

What is the forecasted size of the Global Wearable Injector Market?

The Global Wearable Injector Market is estimated to be worth $12000.44 Million by 2027.

Who are the key companies in the Global Wearable Injector Market?

Key companies in the Global Wearable Injector Market include Amgen Inc., BASF SE, Becton, Dickinson and Company, DCA Design International Ltd, E3D Elcam Drug Delivery Devices, Gerresheimer AG, Insulet Corporation, Johnson & Johnson and Neuma LLC.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases and high demand for advanced drug delivery device
5.1.1.2. Rising demand for minimal invasive treatments
5.1.1.3. Need for subcutaneous and continuous drug delivery
5.1.2. Restraints
5.1.2.1. Low adoption in emerging economies
5.1.3. Opportunities
5.1.3.1. Increasing demand for biologics and mAbs
5.1.3.2. Advancement in injector technology
5.1.4. Challenges
5.1.4.1. Preference for alternative drug delivery modes
5.2. Cumulative Impact of COVID-19
6. Wearable Injector Market, by Type
6.1. Introduction
6.2. Body Worn Patch Injector
6.3. Off Body Worn Patch Injector
7. Wearable Injector Market, by Application
7.1. Introduction
7.2. Autoimmune Disease
7.3. Cardiovascular Disease
7.4. Diabetes
7.5. Infectious Disease
7.6. Oncology
8. Wearable Injector Market, by End Use
8.1. Introduction
8.2. Clinic
8.3. Home Care Setting
8.4. Hospital
8.5. Online Pharmacy
8.6. Retail Pharmacy
8.7. Specialty Clinics
9. Americas Wearable Injector Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Wearable Injector Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Wearable Injector Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Amgen Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. BASF SE
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Becton, Dickinson and Company
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. DCA Design International Ltd
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. E3D Elcam Drug Delivery Devices
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Gerresheimer AG
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Insulet Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Johnson & Johnson
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Medtronic PLC
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Neuma LLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. SCHOTT AG
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. SONCEBOZ SA
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Stevanato Group S.p.A.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Valeritas, Inc.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. West Pharmaceutical Services, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Ypsomed AG
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL WEARABLE INJECTOR MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL WEARABLE INJECTOR MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL WEARABLE INJECTOR MARKET DYNAMICS
FIGURE 11. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 17. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 19. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2021 VS 2027 (%)
FIGURE 25. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY END USE, 2027
FIGURE 27. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
FIGURE 30. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
FIGURE 33. AMERICAS WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 35. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 36. AMERICAS WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 37. ARGENTINA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 38. BRAZIL WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. CANADA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. MEXICO WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 43. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 45. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 47. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 49. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. CHINA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. INDIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. INDONESIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. JAPAN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. MALAYSIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. SINGAPORE WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. TAIWAN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. THAILAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. VIETNAM WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 65. DENMARK WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. EGYPT WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. FINLAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. FRANCE WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. GERMANY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. ISRAEL WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. ITALY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. NIGERIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. NORWAY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. POLAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. QATAR WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. RUSSIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SPAIN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SWEDEN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. TURKEY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. GLOBAL WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 87. GLOBAL WEARABLE INJECTOR MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 88. GLOBAL WEARABLE INJECTOR MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL WEARABLE INJECTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. AMERICAS WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 50. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 52. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 53. ARGENTINA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 54. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 55. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 56. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 57. BRAZIL WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 58. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 59. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 60. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 61. CANADA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 62. CANADA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63. CANADA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 64. CANADA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 65. MEXICO WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. MEXICO WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 67. MEXICO WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 68. MEXICO WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 69. UNITED STATES WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 70. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 71. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 73. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 79. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 80. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 81. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 82. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 83. CHINA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. CHINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 85. CHINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 86. CHINA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 87. INDIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 88. INDIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 89. INDIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 90. INDIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 91. INDONESIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 92. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 93. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 94. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 95. JAPAN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 96. JAPAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 97. JAPAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 98. JAPAN WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 99. MALAYSIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 101. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 102. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 103. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 104. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 105. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 106. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 107. SINGAPORE WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 109. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 110. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 111. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 113. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 114. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 115. TAIWAN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 116. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 117. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 118. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 119. THAILAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 120. THAILAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 121. THAILAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 122. THAILAND WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 123. VIETNAM WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 125. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 126. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 132. DENMARK WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. DENMARK WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 134. DENMARK WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 135. DENMARK WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 136. EGYPT WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 137. EGYPT WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 138. EGYPT WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 139. EGYPT WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 140. FINLAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 141. FINLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 142. FINLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 143. FINLAND WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 144. FRANCE WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. FRANCE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 146. FRANCE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 147. FRANCE WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 148. GERMANY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 149. GERMANY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 150. GERMANY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 151. GERMANY WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 152. ISRAEL WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 153. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 154. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 155. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 156. ITALY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. ITALY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 158. ITALY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 159. ITALY WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 160. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 161. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 162. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 163. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 164. NIGERIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 166. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 167. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 168. NORWAY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 169. NORWAY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 170. NORWAY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 171. NORWAY WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 172. POLAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 173. POLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 174. POLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 175. POLAND WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 176. QATAR WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 177. QATAR WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 178. QATAR WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 179. QATAR WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 180. RUSSIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 181. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 182. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 183. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 184. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 185. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 186. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 187. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 188. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 189. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 190. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 191. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 192. SPAIN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 193. SPAIN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 194. SPAIN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 195. SPAIN WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 196. SWEDEN WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 197. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 198. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 199. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 200. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 202. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 203. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 204. TURKEY WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 205. TURKEY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 206. TURKEY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 207. TURKEY WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 212. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 213. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 214. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 215. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY END USE, 2018-2027 (USD MILLION)
TABLE 216. GLOBAL WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 217. GLOBAL WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 218. GLOBAL WEARABLE INJECTOR MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 219. GLOBAL WEARABLE INJECTOR MARKET RANKING, BY KEY PLAYER, 2021
TABLE 220. GLOBAL WEARABLE INJECTOR MARKET SHARE, BY KEY PLAYER, 2021
TABLE 221. GLOBAL WEARABLE INJECTOR MARKET MERGER & ACQUISITION
TABLE 222. GLOBAL WEARABLE INJECTOR MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 223. GLOBAL WEARABLE INJECTOR MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 224. GLOBAL WEARABLE INJECTOR MARKET INVESTMENT & FUNDING
TABLE 225. GLOBAL WEARABLE INJECTOR MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 226. GLOBAL WEARABLE INJECTOR MARKET: LICENSE & PRICING

Companies Mentioned

  • Amgen Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • DCA Design International Ltd
  • E3D Elcam Drug Delivery Devices
  • Gerresheimer AG
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Neuma LLC
  • SCHOTT AG
  • SONCEBOZ SA
  • Stevanato Group S.p.A.
  • Valeritas, Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG

Methodology

Loading
LOADING...